Cytokine Release Syndrome and Associated Acute Toxicities in Pediatric Patients Undergoing Immune Effector Cell Therapy or Hematopoietic Cell Transplantation

Immune effector cells (IEC) are a powerful and increasingly targeted tool, particularly for the control and eradication of malignant diseases. However, the infusion, expansion, and persistence of autologous or allogeneic IEC or engagement of endogenous immune cells can be associated with significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumeister, Susanne H. C., Mohan, Gopi S., Elhaddad, Alaa, Lehmann, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989409/
https://www.ncbi.nlm.nih.gov/pubmed/35402259
http://dx.doi.org/10.3389/fonc.2022.841117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989409/
https://www.ncbi.nlm.nih.gov/pubmed/35402259
http://dx.doi.org/10.3389/fonc.2022.841117

Ejemplares similares